Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases ; volume:19 ; number:1 ; day:21 ; month:5 ; year:2024 ; pages:1-12 ; date:12.2024
Orphanet journal of rare diseases ; 19, Heft 1 (21.5.2024), 1-12, 12.2024

Creator: Hwang, Austin
Kwon, Andie
Miller, Corinne H.
Reimer-Taschenbrecker, Antonia
Paller, Amy S.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13023-024-03190-1

URN: urn:nbn:de:101:1-2407310914477.121823886108

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:01 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Hwang, Austin
Kwon, Andie
Miller, Corinne H.
Reimer-Taschenbrecker, Antonia
Paller, Amy S.
SpringerLink (Online service)

Other Objects (12)

Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa

Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa

Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa

Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)

Recessive dystrophic epidermolysis bullosa caused by a novel COL7A1 variant with isodisomy

Diversity ofmechanisms underlying latent TGF-[beta] activation in recessive dystrophic epidermolysis bullosa

Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases

STAT3 targeting in dystrophic epidermolysis bullosa

Itch in recessive dystrophic epidermolysis bullosa: findings of PEBLES, a prospective register study

Clinical trial of ABCB5-positive mesenchymal stem cells for recessive dystrophic epidermolysis bullosa

A prevalent mutation with founder effect in Spanish Recessive Dystrophic Epidermolysis Bullosa families

Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa

Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa

Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa

Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa

Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)

Recessive dystrophic epidermolysis bullosa caused by a novel COL7A1 variant with isodisomy

Diversity ofmechanisms underlying latent TGF-[beta] activation in recessive dystrophic epidermolysis bullosa

Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases

STAT3 targeting in dystrophic epidermolysis bullosa

Itch in recessive dystrophic epidermolysis bullosa: findings of PEBLES, a prospective register study

Clinical trial of ABCB5-positive mesenchymal stem cells for recessive dystrophic epidermolysis bullosa

A prevalent mutation with founder effect in Spanish Recessive Dystrophic Epidermolysis Bullosa families

Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa

Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa

Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa

Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa

Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)

Recessive dystrophic epidermolysis bullosa caused by a novel COL7A1 variant with isodisomy

Diversity ofmechanisms underlying latent TGF-[beta] activation in recessive dystrophic epidermolysis bullosa

Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases

STAT3 targeting in dystrophic epidermolysis bullosa

Itch in recessive dystrophic epidermolysis bullosa: findings of PEBLES, a prospective register study

Clinical trial of ABCB5-positive mesenchymal stem cells for recessive dystrophic epidermolysis bullosa

A prevalent mutation with founder effect in Spanish Recessive Dystrophic Epidermolysis Bullosa families

Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa

Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa

Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa

Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)

Recessive dystrophic epidermolysis bullosa caused by a novel COL7A1 variant with isodisomy

Diversity ofmechanisms underlying latent TGF-[beta] activation in recessive dystrophic epidermolysis bullosa

Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases

STAT3 targeting in dystrophic epidermolysis bullosa

Itch in recessive dystrophic epidermolysis bullosa: findings of PEBLES, a prospective register study

Clinical trial of ABCB5-positive mesenchymal stem cells for recessive dystrophic epidermolysis bullosa

A prevalent mutation with founder effect in Spanish Recessive Dystrophic Epidermolysis Bullosa families

Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa

Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa

Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa

Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa

Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)

Recessive dystrophic epidermolysis bullosa caused by a novel COL7A1 variant with isodisomy

Diversity ofmechanisms underlying latent TGF-[beta] activation in recessive dystrophic epidermolysis bullosa

Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases

STAT3 targeting in dystrophic epidermolysis bullosa

Itch in recessive dystrophic epidermolysis bullosa: findings of PEBLES, a prospective register study

Clinical trial of ABCB5-positive mesenchymal stem cells for recessive dystrophic epidermolysis bullosa

A prevalent mutation with founder effect in Spanish Recessive Dystrophic Epidermolysis Bullosa families

Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa

Deconstructing progressive inflammatory fibrosis in recessive dystrophic epidermolysis bullosa

Splicing modulation via antisense oligonucleotides in recessive dystrophic epidermolysis bullosa

Systemic collagen VII replacement therapy for advanced recessive dystrophic epidermolysis bullosa

Pain in recessive dystrophic epidermolysis bullosa (RDEB): findings of the Prospective Epidermolysis Bullosa Longitudinal Evaluation Study (PEBLES)

Recessive dystrophic epidermolysis bullosa caused by a novel COL7A1 variant with isodisomy

Diversity ofmechanisms underlying latent TGF-[beta] activation in recessive dystrophic epidermolysis bullosa

Therapies for cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa: a systematic review of 157 cases

STAT3 targeting in dystrophic epidermolysis bullosa

Itch in recessive dystrophic epidermolysis bullosa: findings of PEBLES, a prospective register study

Clinical trial of ABCB5-positive mesenchymal stem cells for recessive dystrophic epidermolysis bullosa

A prevalent mutation with founder effect in Spanish Recessive Dystrophic Epidermolysis Bullosa families

Histone deacetylase inhibition mitigates fibrosis-driven disease progression in recessive dystrophic epidermolysis bullosa

Related objects

Reset password